Scott Gottlieb

 
Professional Background of Dr. Scott Gottlieb
 

Dr. Scott Gottlieb is a highly respected physician with a remarkable career in healthcare, public policy, and medical innovation. He holds a Doctor of Medicine (MD) from the Icahn School of Medicine at Mount Sinai, where he also completed his residency in Internal Medicine. Additionally, he earned a Bachelor's degree in Economics from Wesleyan University.

 
Tenure at the U.S. Food and Drug Administration (FDA)
 

Dr. Gottlieb's career is distinguished by his notable tenure as the 23rd Commissioner of the U.S. Food and Drug Administration (FDA) from May 2017 to April 2019. During his time at the FDA, he was instrumental in modernizing health regulations and implementing policies that led to a record number of approvals for new drugs, medical devices, and generic medicines. His initiatives in tobacco control, food safety, and addiction crisis interventions have had lasting impacts on public health.

 
Career After FDA
 

Before and after his role at the FDA, Dr. Gottlieb has held various influential positions. He is currently a partner at New Enterprise Associates, a top venture capital firm focused on life sciences and healthcare technology. He also serves as a Senior Fellow at the American Enterprise Institute, where he provides insights on healthcare and public policy.

 
Board Memberships
 

Dr. Gottlieb's contributions extend to numerous board memberships. He is a board member for Pfizer, Illumina, Xaira Therapeutics, Comanche Biopharma, Resilience, Aetion, and Tempus AI, among others. In each of these roles, he leverages his expertise to drive advancements in medical and healthcare services.

 
Recognition and Publications
 

In addition to his professional engagements, Dr. Gottlieb is an elected member of the National Academy of Medicine, demonstrating recognition by his peers for his significant contributions to medical science and healthcare policy.

His work has been widely published in leading medical journals and major periodicals like The Wall Street Journal, The New York Times, and The Washington Post. He has also held editorial positions for prestigious medical journals, including the British Medical Journal and the Journal of the American Medical Association.

 
Media Presence
 

Regularly appearing as a commentator on CNBC, Dr. Gottlieb remains a prominent voice in the healthcare community. His professional journey underscores a deep commitment to public health, innovation, and policy advancement, making him a pivotal figure in both healthcare and public policy sectors.